Navigation Links
SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
Date:8/6/2009

al clinical development for Shire Pharmaceuticals. Prior to joining Shire, Ms. Keller was head of development operations and clinical trial recruitment services for Pfizer Global Research and Development.

An integral part of the company's launch plans for all its diagnostic products is ensuring ongoing dialogue with managed care providers. Joseph Zimmerman recently joined SEQUENOM to oversee this function as vice president of managed care. Previously, Mr. Zimmerman held a number of positions at AmeriPath, most recently as vice president of managed care. Prior to joining AmeriPath, Mr. Zimmerman served as director of managed care, Midwest Division, LabCorp.

2009 Guidance

SEQUENOM is updating its 2009 financial guidance as follows:

Genetic Analysis:

  • Revenues to range between $32 million and $35 million.
  • Gross margin of approximately 57% in 2009.
  • Net loss of approximately $11 million.
  • Cash burn of breakeven to $2 million.

Molecular Diagnostics

  • Revenue guidance is not being provided.
  • Net loss of approximately $54 million.
  • Cash burn of approximately $52 million to $55 million.

Consolidated

  • Net loss of approximately $65 million, which includes approximately $12 million in non-cash FAS 123R expenses.
  • Cash burn of approximately $52 to $57 million. The increase in burn rate is due to increased legal expenses, and increased expenses associated with the ramp up of the company's diagnostics efforts.

About SEQUENOM

SEQUENOM is a life sciences company committed to providing the best genetic analysis products that translate the results of genomic science into solutions for molecular dia
'/>"/>

SOURCE SEQUENOM, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. SEQUENOM Announces Launch of MassARRAY Compact 96 System
2. SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
3. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
4. Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3
5. Sequenom to Webcast Analyst and Investor Briefing Presentation on September 24
6. OncoGenex Reports Second Quarter 2009 Financial Results
7. Repligen Reports First Quarter Fiscal Year 2010 Financial Results
8. PDI Reports 2009 Second Quarter Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
10. Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
11. NxStage Reports Second Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 Applying a well-known optical phenomenon called ... University has demonstrated the ability to "paint" ultra-thin ... holds promise for making future, flexible electronic devices, ... of next-gen rocket ships and spacecraft with extremely ... oil in water, it becomes iridescent, revealing a ...
(Date:9/30/2014)... , Sept. 30, 2014 Report Details ... with highest potential revenues Do you want to ... gives you revenue predictions for those biological drugs ... therapies you find financial data, R&D trends, opportunities ... get sales forecasts to 2024 at overall world ...
(Date:9/30/2014)... 2014 Proove Biosciences , the ... to announce a new genetic test built upon research ... Perception Test will provide physicians with an objective ... tolerance levels are stratified between individuals. With this new ... person has a genetic predisposition that will affect their ...
(Date:9/30/2014)... 2014 Fast, semi-automatic creation ... in documents ChemAxon , a ... services for life science research, launches ChemCurator, an ... structures from documents. Markush structures are ... generating and understanding Markush structures is a difficult ...
Breaking Biology Technology:Taking thin films to the extreme 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 4Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 5Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3ChemAxon Introduces ChemCurator for Chemical Information Extraction and Markush Structure Creation 2
... 28, 2011 The Japanese nuclear crisis has caused ... shortages not only in Japan, but as far away ... potassium iodide does not provide generalized radiation protection because ... being bombarded with orders as the radiation hysteria mounts. ...
... -- In recent years, many airplane manufacturers have started ... of high-strength fibers, such as carbon or glass, embedded ... stronger and more lightweight than aluminum, but they are ... surfaces usually don,t reveal underlying problems. "With aluminum, ...
... VRML ) – Vermillion, a molecular diagnostics company, ... 23, 2011 on Vermillion. This research report ... by contacting, Scott Gleason at scott.gleason@stephens.com . ... is dedicated to the discovery, development and commercialization of ...
Cached Biology Technology:Shortages of Potassium Iodide as Radiation Panic Drives Demand 2MIT engineers devise new way to inspect materials used in airplanes 2Stephens Initiates Coverage on Vermillion 2Stephens Initiates Coverage on Vermillion 3
(Date:9/30/2014)... that a new class of chemical compounds makes ... have also pinpointed the relevant target enzyme, thus ... , Researchers led by LMU,s Professor Angelika Vollmar ... Mnchen have identified a class of chemicals that ... against malignant tumors. The compound is itself non-toxic, ...
(Date:9/30/2014)... , Sept. 30, 2014  Spectra ... solutions for the biotech and power generation ... new RECONN Bioprocess Manager, an easy-to-use and ... geared towards bioprocess development laboratories. ... disparate bioreactor and analyzer systems. Accessing and ...
(Date:9/29/2014)... species of gut bacteria called Clostridium ramosum , coupled ... The work is published this week in mBio , ... , A research team from the German Institute of ... gut bacteria including C. ramosum gained weight when ... C. ramosum were less obese even when consuming a ...
Breaking Biology News(10 mins):Cancer therapy: Driving cancer cells to suicide 2Spectra Automation Introduces RECONN Bioprocess Manager 2Gut bacteria promote obesity in mice 2
... Broadlawns Medical Center is reading palms in order to ... plan and commitment to be the Iowa leader in Electronic ... scanners to register and check-in patients. The new system, called ... Broadlawns Medical Center as part of a week-long launch.   ...
... children were born in public clinics in Denmark, projecting a net ... 50 years respectively. The authors of the study calculated that reductions ... to cost savings of 67 - 111 million for the Danish ... 50 years of age, the government would have lost 74 - ...
... Results from a study of over 50 000 pregnancies ... pregnancy was confirmed gave birth to babies with a ... never smoked, Professor Nick Macklon, from the Department of ... annual conference of the European Society of Human Reproduction ...
Cached Biology News:Broadlawns Installs First-in-Iowa Biometric Patient Identity Security System 2Broadlawns Installs First-in-Iowa Biometric Patient Identity Security System 3The long-term fiscal impact of funding cuts for IVF in Denmark 2Giving up smoking averts the adverse birth outcomes associated with tobacco 2
Request Info...
Shake 'n' Stack oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual)...
... Neural Stem Cell Expansion Kit - Monolayer Plus ... NSC expansion as a monolayer in a ... N-2 Plus Media Supplement, which has been optimized ... et al . (1996) Genes & Development ...
... Description: Topoisomerase I relaxes both positively and negatively ... of phosphodiester bonds (1,2) . Relaxing supercoiled DNA ... by a single nucleotide pair by gel electrophoresis ... absence of Mn 2+ and can be ...
Biology Products: